[Chinese expert consensus of allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia (2022)].
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2022 Oct 14;43(10):793-801. doi: 10.3760/cma.j.issn.0253-2727.2022.10.001.
Abstract
摘要
相似文献
1
[Chinese expert consensus of allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia (2022)].《儿童急性淋巴细胞白血病异基因造血干细胞移植中国专家共识（2022年版）》
Zhonghua Xue Ye Xue Za Zhi. 2022 Oct 14;43(10):793-801. doi: 10.3760/cma.j.issn.0253-2727.2022.10.001.
2
[Chinese expert consensus of the allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia (not APL) (2022)].《儿童急性髓系白血病（非急性早幼粒细胞白血病）异基因造血干细胞移植中国专家共识（2022年版）》
Zhonghua Xue Ye Xue Za Zhi. 2022 Oct 14;43(10):802-809. doi: 10.3760/cma.j.issn.0253-2727.2022.10.002.
3
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.异基因造血细胞移植的非清髓预处理治疗高危急性淋巴细胞白血病。
Haematologica. 2011 Aug;96(8):1113-20. doi: 10.3324/haematol.2011.040261. Epub 2011 Apr 20.
4
Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how.成人急性淋巴细胞白血病的异基因干细胞移植：时机与方式
Haematologica. 2011 Aug;96(8):1083-6. doi: 10.3324/haematol.2011.048348.
5
Outcome Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia Treated with Total Body Irradiation-Free Allogeneic Hematopoietic Stem Cell Transplantation: Comparison of Patients with and Without Central Nervous System Involvement.儿童急性淋巴细胞白血病患者行无全身放疗异基因造血干细胞移植的疗效分析：合并与不合并中枢神经系统累及患者的比较。
Biol Blood Marrow Transplant. 2017 Dec;23(12):2110-2117. doi: 10.1016/j.bbmt.2017.08.036. Epub 2017 Sep 1.
6
Non-myeloablative conditioning before allogeneic stem cell transplantation in adult acute lymphoblastic leukemia.成人急性淋巴细胞白血病异基因干细胞移植前的非清髓性预处理。
Haematologica. 2003 May;88(5):484-6.
7
Allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia.成年急性淋巴细胞白血病患者的异基因造血细胞移植
Hematol Oncol Clin North Am. 2014 Dec;28(6):995-1009. doi: 10.1016/j.hoc.2014.08.008. Epub 2014 Oct 3.
8
Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).欧洲成人急性淋巴细胞白血病患者接受造血干细胞移植的趋势：欧洲血液和骨髓移植学会急性白血病工作组的报告。
Ann Hematol. 2019 Oct;98(10):2389-2398. doi: 10.1007/s00277-019-03771-2. Epub 2019 Aug 7.
9
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.在接受清髓性异基因移植的成人急性淋巴细胞白血病患者中可测量残留病：来自 EBMT 急性白血病工作组的 2780 例患者的回顾性登记研究。
J Hematol Oncol. 2019 Oct 23;12(1):108. doi: 10.1186/s13045-019-0790-x.
10
Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.异基因造血干细胞移植后急性白血病的髓外复发：急性髓系白血病与急性淋巴细胞白血病的不同特征
Biol Blood Marrow Transplant. 2014 Jul;20(7):1040-7. doi: 10.1016/j.bbmt.2014.03.030. Epub 2014 Apr 2.
引用本文的文献
1
Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study.博纳吐单抗治疗中国复发/难治性B细胞急性淋巴细胞白血病患者的疗效与安全性：一项单中心回顾性研究
Front Oncol. 2025 May 12;15:1587185. doi: 10.3389/fonc.2025.1587185. eCollection 2025.
2
[Clinical analysis of 16 cases of adult acute B-lymphoblastic leukemia treated with blinatumomab].[16例成人急性B淋巴细胞白血病患者接受博纳吐单抗治疗的临床分析]
Zhonghua Xue Ye Xue Za Zhi. 2025 Mar 14;46(3):269-272. doi: 10.3760/cma.j.cn121090-20240611-00219.
3
[Analysis on the clinical efficacy and adverse reactions of blinatumomab for the treatment of relapsed/refractory acute lymphoblastic leukemia].[博纳吐单抗治疗复发/难治性急性淋巴细胞白血病的临床疗效及不良反应分析]
Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):516-519. doi: 10.3760/cma.j.issn.0253-2727.2023.06.015.
本文引用的文献
1
Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL.基于CD19特异性嵌合抗原受体T细胞疗法在伴中枢神经系统白血病的B细胞急性淋巴细胞白血病患者中的疗效与安全性
Blood. 2022 Jun 9;139(23):3376-3386. doi: 10.1182/blood.2021013733.
2
Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete Remission.嵌合抗原受体 T 细胞疗法改善首次完全缓解时持续/复发微小残留病的儿童急性淋巴细胞白血病的预后。
Front Immunol. 2022 Jan 7;12:731435. doi: 10.3389/fimmu.2021.731435. eCollection 2021.
3
Total Body Irradiation Forever? Optimising Chemotherapeutic Options for Irradiation-Free Conditioning for Paediatric Acute Lymphoblastic Leukaemia.全身照射会一直存在吗？优化小儿急性淋巴细胞白血病无照射预处理的化疗方案。
Front Pediatr. 2021 Dec 10;9:775485. doi: 10.3389/fped.2021.775485. eCollection 2021.
4
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients.一项多中心 I/II 期临床试验的结果：TCRαβ 和 CD19 耗竭的单倍体相合造血干细胞移植治疗成人和儿童患者。
Bone Marrow Transplant. 2022 Mar;57(3):423-430. doi: 10.1038/s41409-021-01551-z. Epub 2021 Dec 24.
5
Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance.新生儿和婴儿细胞毒药物的临床药理学：提供基于证据的剂量指导。
Eur J Cancer. 2022 Mar;164:137-154. doi: 10.1016/j.ejca.2021.11.001. Epub 2021 Dec 2.
6
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.中华血液学分会关于异基因造血干细胞移植适应证、预处理方案及供者选择的专家共识（2021 年版）
J Hematol Oncol. 2021 Sep 15;14(1):145. doi: 10.1186/s13045-021-01159-2.
7
Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation.抢先输注供体来源的抗CD19嵌合抗原受体T细胞，对异基因造血干细胞移植后微小残留病阳性的B淋巴细胞白血病复发显示出有前景的抗白血病效果。
Leukemia. 2022 Jan;36(1):267-270. doi: 10.1038/s41375-021-01351-w. Epub 2021 Jul 20.
8
Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapy.未处理的单倍体相合造血干细胞移植是 CAR-T 细胞治疗后复发/难治性费城染色体阴性 B 细胞急性淋巴细胞白血病儿童和年轻成人的绝佳选择。
Leukemia. 2021 Nov;35(11):3092-3100. doi: 10.1038/s41375-021-01236-y. Epub 2021 Apr 6.
9
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.Blinatumomab 与化疗治疗高危初发 B 细胞急性淋巴细胞白血病患儿无事件生存的效果：一项随机临床试验。
JAMA. 2021 Mar 2;325(9):843-854. doi: 10.1001/jama.2021.0987.
10
Re-Emergence of Minimal Residual Disease Detected by Flow Cytometry Predicts an Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia.通过流式细胞术检测到的微小残留病再次出现预示着儿童急性淋巴细胞白血病的不良预后。
Front Oncol. 2021 Feb 5;10:596677. doi: 10.3389/fonc.2020.596677. eCollection 2020.
Zotero 插件